Approved indication. In the United States, this combination (often prescribed under the brand name Pylera) is approved only for use with omeprazole to eradicate Helicobacter pylori in adults who have active duodenal ulcer disease or a history of duodenal ulcer within the past several years, because clearing the infection lowers the risk of ulcer coming back.

Off-label use in practice. Clinicians may also use this regimen, or very similar bismuth‑based quadruple regimens, off label to treat H. pylori infection in adults without a documented duodenal ulcer or as a “rescue” regimen after other H. pylori treatments fail; evidence from clinical trials and guidelines shows good eradication rates in these settings, though the official FDA approval is limited to duodenal‑ulcer–associated infection.

Efficacy expectations. In clinical studies, when taken exactly as prescribed with a proton pump inhibitor, this regimen typically eradicates H. pylori in roughly 85–95% of patients, with success rates comparable to or better than many clarithromycin‑based triple therapies, especially where macrolide resistance is common; ulcer pain and indigestion often begin to improve within days and usually improve markedly over several weeks, but a breath test or stool antigen test is usually done at least 4 weeks after finishing therapy (and at least 2 weeks after stopping acid‑suppressing medicine) to confirm that the infection is truly cleared.

Typical adult dosing and how to take it. Adults usually take three capsules by mouth four times a day (after breakfast, after lunch, after the evening meal, and at bedtime) for 10 days, together with omeprazole 20 mg twice daily after the morning and evening meals; each dose should be swallowed whole with a full glass of water while sitting or standing, and patients should avoid lying down for at least 10 minutes afterward to reduce the risk of esophageal irritation from tetracycline.

Food, timing, and other instructions. Take the capsules after meals to lessen stomach upset, avoid taking them with milk or dairy products and avoid antacids or supplements containing aluminum, calcium, magnesium, iron, zinc, or bismuth subsalicylate for about 2–3 hours before and after each dose because these can bind tetracycline and reduce its absorption, and avoid alcohol and products containing propylene glycol during treatment and for at least 3 days after the last dose to prevent a severe disulfiram‑like reaction (flushing, cramping, nausea, vomiting).

Special dosing considerations. This regimen is intended for adults; safety and effectiveness have not been established in pediatric patients, and it should not be used in young children, especially those 8 years and younger, or in patients with severe kidney or severe liver impairment unless a specialist specifically advises and closely supervises its use; patients should always complete the full course even if they feel better to maximize the chance of eradicating H. pylori.

Missed doses and overdose. If a dose is missed, patients should take the next scheduled dose at the usual time without doubling up, continue the regular schedule until all capsules are finished, and contact the prescriber if more than four doses are missed; in case of accidental overdose or someone (especially a child) ingesting a large amount, emergency medical care and a call to a poison control center (in the U.S., 1‑800‑222‑1222) are recommended immediately.

Common side effects. Many patients experience temporary nausea, diarrhea or loose stools, abdominal discomfort, headache, metallic or altered taste in the mouth, dark or black stools, and darkening of the tongue; these usually start during the 10‑day course, are mild to moderate, and resolve after treatment ends.

Serious or rare adverse effects. Seek immediate medical attention for signs of severe allergic reaction (rash, blistering or peeling skin, swelling of face or throat, trouble breathing), severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, severe or persistent diarrhea (especially if watery or bloody, which may signal C. diff infection), new or worsening numbness, tingling, burning, or weakness in the hands or feet, seizures, confusion, trouble speaking, vision changes or severe headache (possible increased pressure in the skull or other neurologic problems), liver problems (yellow eyes or skin, dark urine, severe abdominal pain), or symptoms of aseptic meningitis such as fever, stiff neck, and light sensitivity.

Warnings and precautions. This medicine is contraindicated in pregnancy because tetracycline can harm the fetus and stain developing teeth, and treatment for H. pylori can usually be postponed until after pregnancy; it is generally not recommended while breastfeeding and should be avoided in infants and young children, especially those 8 years and younger, due to effects on teeth and bones. Use is not recommended in patients with severe kidney disease or severe liver disease (especially those with Cockayne syndrome), and caution is needed in people with a history of seizures, peripheral neuropathy, intracranial hypertension, blood disorders, or significant liver impairment. Tetracycline can make skin very sensitive to sunlight, so patients should minimize sun exposure and use protective clothing and sunscreen during and shortly after therapy.

Relative safety compared with other regimens. For most otherwise healthy adults using it for only 10 days, this regimen is generally well tolerated, but it involves many pills per day and combines three agents that each carry their own risks, so neurologic side effects (from metronidazole) and photosensitivity or tooth discoloration (from tetracycline) must be considered; unlike clarithromycin‑based regimens, it avoids macrolides and can be safer from a resistance standpoint in areas with high clarithromycin resistance.

Side-effect reporting and safety updates. Patients should promptly report bothersome or serious side effects to their prescriber or pharmacist, and in the United States they can report suspected adverse reactions directly to the FDA through the MedWatch program (online or at 1‑800‑FDA‑1088), where up‑to‑date safety communications about this drug are also posted.

Drug and substance interactions. Important interactions include alcohol and propylene glycol (which can cause a severe disulfiram‑like reaction with metronidazole), disulfiram itself (risk of serious psychiatric reactions), methoxyflurane anesthesia (risk of fatal kidney toxicity with tetracycline), warfarin and other blood thinners (possible increased bleeding, requiring closer INR monitoring), lithium, phenytoin, and phenobarbital (blood levels may change and need monitoring or dose adjustment), oral contraceptives (effectiveness may be reduced, so a backup nonhormonal method is advised), and other hepatotoxic or neurotoxic drugs that can increase the risk of liver or nerve injury; antacids, sucralfate, multivitamins, iron, zinc, magnesium, calcium supplements, dairy products, and bismuth subsalicylate can bind tetracycline in the gut and should be separated from this medicine by several hours.

Precautions and situations where use may be unsafe. This regimen should not be used in people with known hypersensitivity to bismuth, metronidazole, other nitroimidazoles, or tetracyclines, in pregnant women, or in patients with severe renal impairment, severe hepatic impairment (particularly those with Cockayne syndrome), or recent use of disulfiram; caution and specialist input are recommended in patients with a history of seizures, peripheral neuropathy, intracranial hypertension, blood dyscrasias, or significant liver disease, and concomitant oral retinoids (such as isotretinoin) should generally be avoided because of the additive risk of increased intracranial pressure.

Monitoring needs. For most healthy adults on a single 10‑day course, routine lab monitoring is not required, but in patients with liver disease, blood disorders, or those taking interacting medicines such as warfarin, lithium, or phenytoin, clinicians may monitor liver function tests, blood counts, drug levels, and coagulation more closely; regardless of comorbidities, follow‑up testing (usually urea breath test or stool antigen) at least 4 weeks after therapy and at least 2 weeks after stopping proton pump inhibitors is recommended to confirm H. pylori eradication.

Q: What is this combination medicine used for?
A: It is a three‑drug capsule taken with a proton pump inhibitor (such as omeprazole) to eradicate Helicobacter pylori infection in adults who have or have had duodenal ulcers, which helps relieve symptoms and lowers the chance of ulcers coming back.

Q: Can I drink alcohol while taking these capsules?
A: No; drinking alcohol or using products that contain alcohol or propylene glycol during treatment and for at least 3 days after the last dose can cause a severe reaction with flushing, cramping, nausea, vomiting, and headache, so alcohol should be strictly avoided.

Q: Why are my tongue and stools turning black?
A: Bismuth in the capsules can temporarily darken the tongue and make stools look black, which is expected and harmless and should go away within a few days after you finish the medicine, but any tarry stools with weakness or dizziness should still be discussed with your doctor to rule out bleeding.

Q: What should I do if I miss a dose?
A: Do not double up; simply take the next scheduled dose at the usual time, keep following the regular schedule until the capsules are gone, and contact your prescriber for advice if you have missed more than four doses in total.

Q: Can I take this medicine if I am pregnant, breastfeeding, or under 18?
A: This regimen is intended for adults and is contraindicated in pregnancy, generally not recommended while breastfeeding, and not approved for children or adolescents, especially those 8 years and younger, so people in these groups should not use it unless a specialist has carefully evaluated the risks and chosen a different plan.

Q: Are there foods, vitamins, or other medicines I should avoid?
A: You should avoid milk and other dairy products, antacids, and mineral supplements containing calcium, magnesium, aluminum, iron, or zinc around the time of each dose (separate by a few hours), avoid alcohol and propylene glycol, and tell your prescriber about all medicines you take—especially blood thinners, seizure medicines, lithium, oral contraceptives, retinoids, and disulfiram—so doses can be adjusted or alternatives chosen if needed.

Storage. Store the capsules at room temperature (about 68–77°F / 20–25°C), in the original blister pack, away from moisture, heat, and direct light, and keep them out of reach of children and pets.

Handling. Do not remove a capsule from the blister until you are ready to take it, and do not use capsules that are damaged, discolored, or past the expiration date.

Disposal. If you have leftover or expired capsules, take them to a pharmacy or community medication take‑back program when possible; if none is available, mix the capsules (removed from the blister) with an undesirable substance such as used coffee grounds or cat litter, seal in a bag or container, and place in household trash, and do not flush them down the toilet unless specifically instructed on the label.